Last week, Bristol-Myers Squibb Co. announced that its diabetes drug dapagliflozin, in combination with metformin, significantly reduced levels of glycosylated hemoglobin in Type 2 diabetes patients as compared to placebo plus metformin in a late-stage study.

High-dose atorvastatin may reduce the incidence and recurrence of foot ulcers in diabetic patients, according to a new report.

Women with metabolic syndrome in early pregnancy have a higher risk for preterm birth, according to study findings.

In some HIV-infected patients, using glycated hemoglobin (A1c) to monitor glucose levels will underestimate the degree of glycemia, and fructosamine may be a better target researchers report. 

Emergency department patients with diabetes who said they had a primary care provider had better glycemic control than patients who did not have a primary care provider, according to the results of an observational study. 

Diets high in animal protein or just total protein are associated with an increased diabetes risk.

A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.

Extreme obesity and a greater burden of chronic disease are linked to higher mortality rates after bariatric surgery. according to the results of a prospective study.

“Superfood” supplements, thought to help fight cancer, may increase the risk of developing diabetes and even shorten lifespan, scientists have revealed.

Initiating insulin therapy with insulin aspart 30/70 (BIAsp 30) improved glycemic control in insulin-naïve patients with Type 2 diabetes who had poor glycemic control with oral antidiabetic drugs, according to new data.